Erin N. Kobetz

University of Miami Miller School of Medicine
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (7)

Background: Social adversity from neighborhood disadvantage (ND) is associated with shorter breast cancer survival. Although studies have identified associations between ND and DNA methylation (DNAme) or gene expression (mRNA), a study integrating DNAme and mRNA to understand how the epigenome regulates key biological pathways in ND merits further inquiry. Methods: DNAme-, mRNA-, miRNA-, and tRNA-derived fragment data were analyzed from 80 estrogen receptor+/HER2− breast cancer samples. We analyzed the association among ND, DNAme, coding, and noncoding data to understand how the epigenome regulates biological pathways. Results: Twenty-five patients lived in ND and 55 in neighborhood advantage. In patients from ND, calcium signaling and cell adhesion pathways were hypermethylated, immune-related pathways hypomethylated, immune response genes upregulated, and estrogen response genes downregulated. Small RNA analysis showed differential expression of miRNA isoforms and tRNA-derived fragments related to ND. Subjective ND further correlated with epigenetic changes in calcium signaling, cell adhesion, and metabolic pathways, along with upregulation of proliferative and stemness pathways. Conclusions: We discovered novel associations between ND and epigenomic regulation of clinically relevant oncogenesis pathways associated with aggressive biology, such as estrogen response pathways. These findings lay the foundation for multi-institutional studies to validate our findings. Impact: This study demonstrates that ND, which is associated with shorter breast cancer survival, is also associated with epigenetic reprogramming of key oncogenesis pathways. These findings highlight pathways through which ND may affect tumor biology and lay the foundation for cancer control policy and behavioral interventions that may reverse the negative effects of ND on cancer biology.

Year:

2025

Background: Previous survival studies on hepatocellular carcinoma (HCC) by etiology are limited to hospital-based series, restricted cohorts, and monolithic etiologic categories. We studied population-based survival by seven mutually exclusive HCC etiologic groups—standalone hepatitis-C virus (HCV), hepatitis-B virus (HBV), alcohol-related liver disease (ALD), nonalcoholic fatty liver disease (NAFLD), and dual etiology HCV–HBV, HCV–ALD, and HBV–ALD—accounting for clinical and sociodemographic characteristics. Methods: All HCC cases diagnosed during 2005 to 2018 from the Florida Cancer Registry were linked for etiology using statewide discharge and viral hepatitis data. We performed a cause-specific survival analysis including Cox regression for the matched 15,616 cases by HCC etiology. Results: The leading etiology was HCV only ( n = 4,983; 31.9%); the leading dual etiology was HCV–ALD ( n = 2,552; 16.3%). The five-year adjusted survival was low—17.6% overall and Conclusions: ALD only and dual etiologies involving ALD show worse prognosis for HCC compared with viral etiology alone. To increase survival, improved screening and treatment are needed for patients with multiple HCC risk factors. Impact: Understanding US disparities in HCC survival by etiology can help guide the identification of etiologically specific biomarkers and potential therapeutic targets and inform public health measures.

Year:

2024

5. Supplementary Table S5 shows age-adjusted 5-year HCC-specific survival by single etiology or select dual etiology groups, a sensitivity analysis for all HCC cases and for complete HCC cases.

Year:

2024

4. Supplementary Table S4 shows multivariable Cox proportional hazards regression models in which HCC-specific survival is assessed based on period of diagnosis, prior or during 2013 and after 2013, for HCV only cases and for non-HCV related cases.

Year:

2024

1. Supplementary Table S1 shows International Classification of Diseases discharge codes used to define the following hepatocellular carcinoma etiologies: chronic hepatitis C virus infection, chronic hepatitis B virus infection, alcohol-related liver conditions, metabolic/non-alcoholic fatty liver disease-related conditions, biliary conditions, autoimmune conditions, and genetic conditions.

Year:

2024

3. Supplementary Table S3 shows a multivariable Cox proportional hazards regression model in which HCC-specific survival is assessed based on cigarette smoking status, with the reference population of past smokers.

Year:

2024

Background: Cervical cancer disparities exist in the United States with the highest incidence in Hispanic women and the highest mortality in Black women. Effective control of cervical cancer in the population requires targeted interventions tailored to community composition in terms of race, ethnicity, and social determinants of health (SDOH). Methods: Using cancer registry and SDOH data, geospatial hot spot analyses were carried out to identify statistically significant neighborhood clusters with high numbers of cervical cancer cases within the catchment area of an NCI-Designated Cancer Center. The locations, racial and ethnic composition, and SDOH resources of these hot spots were used by the center's community outreach and engagement office to deploy mobile screening units (MSU) for intervention in communities with women facing heightened risk for cervical cancer. Results: Neighborhood hot spots with high numbers of cervical cancer cases in south Florida largely overlap with locations of poverty. Cervical cancer hot spots are associated with a high percentage of Hispanic cases and low SDOH status, including low income, housing tenure, and education attainment. Conclusions: A geospatially referenced cancer surveillance platform integrating cancer registry, SDOH, and cervical screening data can effectively identify targets for cervical cancer intervention in neighborhoods experiencing disparities. Impact: Guided with a data-driven surveillance system, MSUs proactively bringing prevention education and cervical screening to communities with more unscreened, at-risk women are an effective means for addressing disparities associated with cervical cancer control.

Year:

2023

Collaborators (11)

Patricia D. Jones

University of Miami Miller School of Medicine

UNITED STATES
View details

Robert J. Wong

Stanford University School of Medicine

UNITED STATES
View details

Aristeidis Telonis

Research Assistant Professor

University of Miami

UNITED STATES
View details

Maria Eugenia Figueroa

Professor

University of Miami School of Medicine

UNITED STATES
View details

Fernando Collado-Mesa

Professor

University of Miami

UNITED STATES
View details

Isildinha Reis

Research Professor

University of Miami Health System

UNITED STATES
View details

Nipun B. Merchant

University of Miami Miller School of Medicine

UNITED STATES
View details

Lluis Morey

Assistant Professor

University of Miami School of Medicine

UNITED STATES
View details

Monica M Yepes

University of Miami Miller School of Medicine

UNITED STATES
View details

Susan Kesmodel

Professor

University of Miami School of Medicine

UNITED STATES
View details

Paulo S. Pinheiro

University of Miami Miller School of Medicine

UNITED STATES
View details